Landscapes / Companies
VelaVigo Bio Inc not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
5 in Phase 2
Drugs
5
in active trials
Trials
5 active
5 since 2021
Drugs5
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 1 Jul 2027Phase 1/2 trial completes | |||
| Next date | 1 Jul 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Participants With Advanced Solid Tumor Malignancies | ||||
| Open drug page | |||||
— |
Phase 1/2 | 1 Dec 2027Phase 1/2 trial completes | |||
| Next date | 1 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Participants With Advanced Solid Tumor Malignancies | ||||
| Open drug page | |||||
— |
Phase 1/2 | 1 Dec 2028Phase 1/2 trial completes | |||
| Next date | 1 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Participants With Advanced Solid Tumor Malignancies | ||||
| Open drug page | |||||
— |
Phase 1/2 | 27 Feb 2029Phase 1/2 trial completes | |||
| Next date | 27 Feb 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | 7 Jul 2029Phase 1/2 trial completes | |||
| Next date | 7 Jul 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021